SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (3)9/28/1999 10:45:00 AM
From: Edscharp   of 75
 
Opal,

Good idea for a thread.

I came to the conclusion about a year ago not to invest in early biotech startups. With the ocassional exception, I now confine my biotech investments to companies that have at least one P3 clinical trial for a large target group and preferably have several ongoing P2 trials in the works. ISIP and IMCL are on the list and, unfortunately, XOMA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News